Table 2.
Gleason score | Patient group |
---|---|
Gleason 6 | 89/159 = 56% |
Gleason 3 + 4 | 58/159 = 36.5% |
Gleason 4 + 3 | 12/159 = 7.5% |
Tumour stage | Patient group |
cT1c | 129/159 = 81% |
cT2a | 30/159 = 19% |
Percentage of positive biopsies | Patient group |
<50% | 131/159 = 82% |
≥50% | 28/159 = 18% |
Gleason score preoperatively | Percentage of tumour recurrence |
Gleason 6 | 3/89 = 3.4% |
Gleason 7 | 6/70 = 8.6% |